ABSTRACT
The purpose of this study was to evaluate the occurrence of clinical coccidiosis in broilers immunosuppressed with dexamethasone. Male and female broiler chickens, from 35 to 38 days old were divided into 3 groups – group I (n = 25), including chickens without coccidiosis and negative for coccidia in fecal examination; group II (n = 25), including birds with coccidiosis and positive for coccidia in fecal examination; group III (n = 25), constituted by chickens with no coccidiosis, negative for coccidia in fecal examination and immunosuppressed with dexamethasone (4 mg/kg/day for 4 days, subcutaneous route). The diagnosis of coccidiosis was achieved using the centrifugal floatation technique in sucrose solution to investigate the presence of oocystis in stools, as well as by the observation of macroscopic and microscopic changes in the gut after necropsy. The immune response was evaluated by determination of cutaneous basophil hypersensitivity (CBH) response to phytohemagglutinin (PHA) and of the weight ratio of bursa of Fabricius and spleen in relation to body weight. Broilers from group II and III presented decreased CBH reaction to PHA in relation to group I, suggesting a decrease of the immune response. In addition, chickens from group III presented a significant decrease in the weight of the bursa of Fabricius and of the spleen. The coccidian types were E. acervulina and E. maxima in chickens from groups II and III, as well as E. tenella in chickens treated with dexamethasone. Immunosuppression induced by dexamethasone increased susceptibility to natural coccidiosis in commercially raised broiler chicks.
KEY WORDS
Broiler chicks; coccidiosis; dexamethasone; immunosuppression
Thumbnail
Thumbnail
